Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

LSCN and TCG Form Collaboration

Published: Monday, June 03, 2013
Last Updated: Monday, June 03, 2013
Bookmark and Share
News attracts medical device, diagnostic and biotechnology companies interested in US or European market expansion.

LSCN Ltd. and the Technology Commercialization Group (TCG) have created an international strategic partnership to help life science companies with transatlantic business development and corporate development projects.

“We’re delighted to be working with LSCN, a premier European life sciences consulting firm”, said Ken West, Managing Partner of TCG.

West continued, “They have the skills, local experience and ‘on-the-ground’ presence necessary to help our US-based clients develop and implement European market entry and growth strategies”.

The US and Europe are the two largest life science, medical device, biotech and pharmaceutical markets in the world, but they have vastly different regulatory, reimbursement, marketing and legal environments.

Life science companies who have developed and marketed a product on one continent often find that developing business across the Atlantic is a challenge. This is especially true for emerging and mid-sized companies.

Dr. Alrik Koppenhöfer, Managing Director & Partner of LSCN, commented “Many European companies aim to internationalize their business, especially in the US marketplace, but are concerned about the FDA, US lawyers and the resources necessary to effectively compete. TCG has guided many European companies in entering or expanding in the US, so they know what works well. Vice versa, LSCN supports many companies in Europe’s multi-cultural and diverse legal and business environment to implement customized solutions”.

In addition to providing services for transatlantic corporate development and growth, both LSCN and TCG provide specialized life science product development oversight as well as interim management for corporate expansion efforts.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!